Aprea Therapeutics, Inc.

Q1 2023 13F Holders

Symbol
APRE
CUSIP
03836J201
Type
Equity
Class
COM NEW
Num filings
17
Total reported value, excl. options
$3.77 M
Manager Report Date Value ($000) Shares Option Type